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SUMMARY
Aim: Lip cancer is one of the most common cancers of the head and 
neck region. Among all lip malignancies, squamous cell carcinoma is most 
common, whereas basal cell carcinoma accounts for only 1% of all lip car-
cinomas. The aim of this paper was to evaluate the frequency of lip lesions 
among Serbian population and to consider its outcome.
Material and Method: The analysis encompassed 479 patients who 
were hospitalized at the Clinic of Maxillofacial Surgery (Faculty of Dentist-
ry, University of Belgrade) during the period 1989-2005 for the treatment 
of lip lesions. The following parameters were analyzed: sex, age, size and 
localization of the lesion, duration of hospitalization, TNM classification, 
histopathologic analysis, type of surgical procedure, other possible treat-
ment, and a recurrence rate.
Results: There were majority of males  (78%). Average age of our 
patients was 63.4 years. Lesions were most often localized in the lower lip 
(88%), and less frequently in the upper lip (8%) or at the lip angle  (4%). 
Average size of the lesion was 24.3 mm. Data confirmed that the “W” exci-
sion was the most frequently used surgical procedure, and for bigger lesions, 
surgical reconstruction was performed by the technique suggested by Kara-
pandzic. Histopathologic analysis confirmed the most frequent incidence of 
the squamous cell carcinoma.
Conclusion: Squamous cell carcinoma of the lip generally has a 
favourable prognosis. Early detection is very important for its successful 
treatment.
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Introduction
Squamous-cell carcinoma (SCC) of the head and 
neck is one of the most common cancers, with a global 
incidence of 500,000 cases per year6. SCC of the lip is 
a relatively common malignancy of the head and neck 
region, accounting for approximately one quarter of 
all oral cavity cancers10. Basal cell carcinoma (BCC) 
accounts for only 1% of all lip carcinomas11, while other 
malignancies of the lip have also been reported, but are 
less common11.
The lip cancer is one of the most easily diagnosed, 
with a generally good prognosis10. Although this form of 
cancer is generally curable compared with other head and 
neck malignancies, regional metastases, local recurrence, 
and even death from this disease may occasionally 
occur10. Moreover, in some individuals, lip cancer may 
behave aggressively, which is manifested by recurrence 
of the lesion after surgical removal, or mortality rate up to 
15% of patients11..
The single most important prognostic factor for SCC 
of the head and neck is complete surgical removal of the 
neoplasm, because it is generally believed that failure to 
eradicate the primary tumour is the leading cause of death 
from this type of cancer. Surgical resection is the principal 
treatment for the majority of advanced-stage carcinomas 
of the upper aero-digestive tract and a frequent choice 
in treating early lesions as well6. Selection of a specific 
regional flap depends on the type of defect, i.e. its size and 
location, and on the intrinsic properties of the regional flap8.
*Some of the presented results in this paper have been reported at the 12th 
Congress of the BaSS, held in Istanbul, 2007
Early cancers of the lip and oral cavity (stage I and 
stage II) are highly curable by surgery alone, or along 
with radiation therapy, and the choice of treatment is 
dictated by the anticipated functional and cosmetic results 
of treatment8. However, the behaviour of lip cancer 
generally resembles skin cancer more than carcinoma of 
mucosal origin in the oral cavity proper11. The presence 
of a positive margin of the resected lesion significantly 
increases the risk of local recurrence, as well as the depth 
of the tumour being >5 mm, suggesting that the combined 
treatment may be beneficial2.
The aim of this investigation was to evaluate the 
frequency of lip cancers among Serbian population and to 
consider its outcome after surgical treatment.
Patients and Methods
The research is planned as a retrospective study, done 
at the Clinic of Maxillofacial Surgery at the Faculty of 
Dentistry, University of Belgrade, during the period 1989-
2005. During this period 463 patient were admitted with 
the diagnosis “tumour of the lip”. The data were gathered 
from medical histories of patients, and were entered in 
particular examination forms in Microsoft Access and 
Microsoft Excel programme.
The following parameters were analysed: sex, age, 
period between noticing first symptoms and the beginning 
of therapy, localisation and size of the lesion, presence of 
suspect lymph nodes, type of operation, histopathologic 
analysis, duration of hospitalization and recurrence rate.
Results
The lip lesion were found in 360 males (78%) and 
103 females (22%). Average age of our patients was 63.4 
(ranging between 11 and 96 years of age). We noticed 
that usually less then 6 months elapsed from noticing first 
symptoms and coming for the treatment (41%). Mean 
diameter of the lesion was 23.3 mm (2-82 mm in range).
The lip lesions most frequently developed at the 
lower lip, followed by the upper lip and lip angle (Fig. 
1). We found suspect lymph nodes in 53 patients (11%) 
in the submandibular region, and in 9 patients (2%) in the 
submental region (Fig. 2).
The „W“ excision was the most frequently used 
surgical technique, followed by „V“ excision and lip 
shave procedure (Fig. 3). The lip reconstruction using 
Karapandzic’s mioarterial flap was performed in 63 
patients - 14% (Fig. 4), followed by Fries reconstruction, 
in 48 patients or 10%. Average duration of hospitalization 
was 12 days. 60 patients (14.9%) had infection in the 
postoperative period, 2 patients had necrosis, while in only 
1 patient tracheotomy was required. During the follow up 
period of the study, recurrence developed in 49 patients 
(11.7%).
Histopathologic analysis of the resected lesions 
mainly showed malignancy (402 cases, 87%), and benign 
lesions were found in 61 cases, or 13%. SCC was the most 
common finding at the lower lip (354 patients or 86%), 
and BCC was found in only 4 patients (1%). At the upper 
lip, BCC has been more often reported (12 patients or 
35%) than SCC (9 patients - 26%). 
Figure 1.
Figure 2.
Figure 3.
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Discussion
Lip cancer represents the most frequent malignant 
neoplasm of the oral cavity. This study provides 
information about the clinicopathologic features of 
patients with SCC of the lip and describes the treatment 
modalities performed.
A previous study9 from the same institution (Clinic 
of Maxillofacial Surgery, Faculty of Dentistry, University 
of Belgrade) showed that total of 223 patients with SCC 
of the lip, were diagnosed and treated during a 10-year 
period between 1991 and 2000. We noticed that from 
2001 to 2005, in a 5-year shorter period, 157 patients 
with SCC were surgically treated. This increased number 
of the patients from 2001 to 2005 could be explained by 
the fact that all patients with SCC of the lip were treated 
as in-patients at the Faculty Clinic; before that period 
(between 1989 and 2001), patients with “small” lip lesions 
were usually treated at the out-patient basis. We analyzed 
only the patients which were hospitalized. We found that 
the lip lesion developed in the lower lip in 88% patients 
with lip cancers. We also found suspect lymph nodes in 
13% (62) of patients.
The retrospective study performed in 113 patient11 
shown that there were 74 men (65.5%) and 39 women 
(34.5%) with tumours of the lip, aged from 14 to 106 
years. Several researches indicated the lower lip as 
the most common site for lip cancer (88-98%), with 
only 2-7% arising from the upper lip and 4% at the lip 
commissures1,5,11. The most common age at diagnosis is 
54 to 65 years.
Although a condition seen in middle age, lip cancer 
occasionally occurs in patients under age 30 years. Lip 
cancer has a predilection for men, with men to women 
ratios ranging from 35:1 to 6:1, depending on the location 
of the lesion5.
Early diagnosis and the surgical treatment are the 
only proper solutions in the diagnosis and therapy of these 
lesions. We need an urgent awareness campaign, and 
programmes for the prevention and early detection of lip 
cancer. The average time between the first symptom and 
therapy was less then 6 months. It is very important to 
distinguish precancerous lesions (leukoplakia, eritroplakia, 
and actinic cheilitis), which pathologically may correspond 
to intraepithelial dysplasia, hyperkeratosis, carcinoma in 
situ, or SCC7.
Several methods for treatment of SCC of the lip are 
available, including surgery, radiotherapy, chemotherapy, 
and combination of these. The primary goals of treatment 
are the following: total removal of the lesion, prevention 
of relapse, and maintenance of quality of life3. With 
overall cure rates of 80 to 90%, lip cancers have a more 
favourable prognosis than most other head and neck 
cancers. The most performed surgical action was „ W 
“excision, followed by „ V “excision. We have particularly 
good experiences in the reconstruction of the lower lip 
using the Karapandzic mioarterial advancement flap, 
developed by Karapandzic in the early 1970s at our clinic9. 
The reconstruction made by Karapandzic mioarterial flap 
was performed in 10 % (48) of patients.
Approximately 85 to 95% of all oral cancer is 
SCC8,9. The study from Mexico4 shown that there 
were 82 SCC (83.7%), 10 (10.2%) BCC, and 6 other 
diagnoses (adenocarcinoma melanoma, adenoid cystic 
carcinoma, Merkel cell carcinoma, lympho-epithelioma 
and angiosarcoma). Cervical lymph node metastases were 
found in 21% of patients with no previous treatment, and 
they developed in 5.3% after treatment1.
References
1.  Broders AC. Squamous-cell epithelioma of the lip: a study of 
five hundred and thirty-seven cases. In: Peterson’s principles 
of oral and maxillofacial surgery. 2nd ed. London: Hamilton, 
2004; p 659.
2.  Harrison LB, Sessions RB, Hong WK, eds: Head and Neck 
Cancer: A Multidisciplinary Approach. Philadelphia: 
Lippincott-Raven, 1999; pp 100-110.
3.  Jones KR, Lodge-Rigal RD, Reddick RL, et al. Prognostic 
factors in the recurrence of stage I and II squamous cell 
cancer of the oral cavity. Arch Otolaryngol Head Neck Surg, 
1992; 118(5):483-485.
4.  Luna OK, Güemes MA, Villavicencio VV, Mosqueda T. A 
lip cancer experience in Mexico. An 11-year retrospective 
study. Oral Oncol, 2004; 40(10):992-999.
5.  Martin H, MacComb WS, Blady JV. Cancer of the lip. Part I. 
Ann Surg, 1941; 114:226.
6.  Parkin DM, Laara E, Muir CS. Estimates of the worldwide 
frequency of sixteen major cancers in 1980. Int J Cancer, 
1988; 41:184-197.
Figure 4.
Balk J Stom, Vol 12, 2008 Lip Cancer in Serbian Population  37
7.  Po Wing Yuen A, Lam KY, Lam LK, et al. Prognostic factors 
of clinically stage I and II oral tongue carcinoma - A 
comparative study of stage, thickness, shape, growth pattern, 
invasive front malignancy grading, Martinez-Gimeno score, 
and pathologic features. Head Neck, 2002; 24(6):513-2002.
8.  Sykes AJ, Allan E, Irwin C. Squamous cell carcinoma of 
the lip: the role of electron treatment. Clin Oncol (R Coll 
Radiol), 1996; 8(6):384-386.
9.  Vukadinovic M, at all. Surgical Management of Squamous 
Cell Carcinoma of the Lip: Analysis of a 10-Year Experience 
in 223 Patients. J Oral Maxillofac Surg, 2007; 65:675-679
10.  Teichgraeber JF, Larson DL. Some oncologic considerations 
in the treatment of lip cancer. Otolaryngol Head Neck Surg 
1988; 98:589-592.
11. Zitsch RP, Park CW, Renner GJ, et al. Outcome analysis for lip 
carcinoma. Otolaryngol Head Neck Surg, 1995; 113:589-596.
Correspondence and request for offprints to:
Milan Petrović 
Faculty of Dentistry 
Clinic of Maxillofacial Surgery 
Dr Subotića 4 
11000 Belgrade, Serbia
